Bioplate
Bioplate designs and manufactures cranial closure and bone fixation systems, including titanium plates, customized PEEK implants, and bioresorbable bone scaffolds, serving neurosurgeons, maxillofacial surgeons, and hospitals across the United States through a distributor and direct sales network.
- Company typePrivate
- Founded1995
- HeadquartersPlacentia, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioplate does
Bioplate, Inc. is a privately-held medical device company founded in 1995 and headquartered in Placentia, California (Orange County). The company designs, manufactures, and distributes cranial closure and bone fixation systems used in neurosurgery and maxillofacial surgery. Its product portfolio spans traditional titanium plates and screws for bone flap fixation, pre-packaged customizable sterile kits with a three-year shelf life, the PRO-DEX surgical driver, the AURA wireless intracranial pressure monitor, customized CRANIOFIT PEEK craniofacial plates manufactured from patient CT scan data, and bioresorbable 3D-printed PCL bone scaffolds (Osteoplug, Osteostrip, Osteomesh) distributed in the US under a 2022 partnership with Singapore-based Osteopore.
Bioplate operates an ISO 13485-certified quality system and serves neurosurgeons, maxillofacial surgeons, and hospitals/health systems through a hybrid commercial model: an independent US distributor network with modular contracts and exclusive territories, supplemented by direct field sales for custom and enterprise orders. Pricing is quote-based procurement typical of medical device hardware, with revenue generated primarily through one-time hardware sales per surgical procedure and, for customized PEEK implants, a consultative per-case design and manufacturing workflow. Distribution has historically been supplemented by contract manufacturing services, and the company also operates the company-sponsored Cranial Closure Podcast as a top-of-funnel educational channel targeting the neurosurgical community.
The company was originally distributed worldwide by Johnson & Johnson for approximately 20 years (notably reaching 40% CAGR in China from 2003-2008 under J&J), was acquired back to independence in 2011, and rebuilt its commercial organization under subsequent leadership (President Thomas Hopson from Edwards Lifesciences in 2018, VP Global Sales Alan Zhu from J&J China/Kontour in August 2021). Bioplate reports involvement in over 500,000 surgical cases worldwide since founding and received the 2022 Orange County Business Journal "Company That Cares" recognition.
Bioplate firmographics
Firmographics- Name
- Bioplate
- Legal name
- Bioplate, Inc.
- Website
- https://bioplate.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bioplate designs and manufactures cranial closure and bone fixation systems, including titanium plates, customized PEEK implants, and bioresorbable bone scaffolds, serving neurosurgeons, maxillofacial surgeons, and hospitals across the United States through a distributor and direct sales network.
- Ownership category
- akta.pro rank
Bioplate industry classification
Industry- Product category
- Cranial and Maxillofacial Fixation Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)
- akta.pro secondary industries
- Maxillofacial Prosthetics & Craniofacial Appliances (HLABAJAH), Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
Keywords
Where Bioplate is headquartered
LocationHeadquarters
- HQ city
- Placentia
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Bioplate business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales - Cranial Fixation Products: Direct sales of titanium plates, screws, sterile kits, and fixation hardware to hospitals and surgical centers. One-time purchase model per surgical procedure with potential for recurring orders from established accounts.
- Customized PEEK Implants: Patient-specific cranial implants designed from CT scans and manufactured to order. Premium pricing for customization, process involves consultation, design approval, and manufacturing.
- Bioresorbable Bone Scaffold Distribution: Distribution partnership revenue from Osteopore products (Osteoplug, Osteostrip, Osteomesh). Products sold through same distributor network as core products.
- Contract Manufacturing Services: Strategic expansion into medical device contract manufacturing services. Looking to diversify service portfolio and attract new customers in medical device sector.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Customized PEEK plates - quote-based pricing |
| Unit Pricing | Pay-as-you-go | Sterile kits with 3-year shelf life |
| Other | Annual | Executive compensation - Dr/Sr Director of Contract Manufacturing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Bioplate product offering
Product offeringCore offering
Bioplate designs, manufactures, and distributes cranial closure and bone fixation hardware for neurosurgery and maxillofacial surgery. Its core offerings include titanium plates and screws, pre-configured sterile kits, the PRO-DEX surgical driver, the AURA wireless intracranial pressure monitor, Osteopore bioresorbable PCL bone scaffolds (Osteoplug, Osteostrip, Osteomesh) distributed in the US, and patient-specific CranioFit PEEK cranial plates manufactured from CT data. Products are sold primarily to hospitals and surgeons through a US distributor network and direct sales.
Product overview
Bioplate is a medical device company specializing in cranial and craniofacial surgery products. The company offers a portfolio of fixation solutions including traditional titanium plates and screws, customizable sterile kits, surgical drivers, wireless ICP monitoring, bioresorbable bone scaffolds via Osteopore partnership, and customized PEEK cranial plates. Products are designed for neurosurgery and maxillofacial surgery applications, with a focus on patient-specific solutions and regenerative technologies.
Differentiator
Problem solved
Functional benefit
Brands
- CranioFit: Customized PEEK craniofacial plates designed to address complex cranial deformities using clinically-proven bioengineered material.
- Osteopore
- AURA
- PRO-DEX Surgical Driver
Quantifiable outcome
- Over 500,000 surgical cases completed successfully
- +2 more outcomes
Companies that use Bioplate
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Bioplate technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bioplate partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Osteoporecore/flagshipBioplate announced partnership with Osteopore in March 2022 to distribute their bioresorbable bone scaffold products in the United States. Osteopore is a global leader in regenerative solutions and the first company to successfully apply bioresorbable materials to achieve cranial regeneration. Products (Osteoplug, Osteostrip, Osteomesh) are 3D-printed PCL implants that promote natural bone regeneration and fully absorb within 18-24 months. The partnership extends Osteopore's reach from Asia, Europe, Australia, and Americas to include the US market.
Scale indicators6 records
Recent moves8 records
Expansion highlights5 records
Bioplate competitors and assessment
Company assessmentBroad incumbents
- DePuy Synthes (Johnson & Johnson): DePuy Synthes is Bioplate's most consequential historical peer — it distributed Bioplate products globally for ~20 years — and remains a dominant competitor in CMF plating, screws, and neurosurgical instruments today. Comparable on product line and customer base, but with vastly greater scale.
- Zimmer Biomet: Zimmer Biomet offers CMF plating systems and craniomaxillofacial fixation products that compete with Bioplate's titanium plate portfolio. As a broad orthopedic incumbent it competes primarily on IDN contracts and full-portfolio bundling rather than cranial specialization.
- Stryker (CMF / Neurotechnology): Stryker's neurosurgical and CMF portfolios include cranial fixation systems and surgical instruments competing with Bioplate across hospitals. As a multi-billion-dollar medtech incumbent, Stryker competes on scale, broad contracts, and integrated OR solutions rather than specialization.
- B. Braun / Aesculap: Aesculap (B. Braun's surgical division) manufactures CMF plates, screws, and surgical instruments that overlap with Bioplate's portfolio. As a broad surgical incumbent, it competes primarily through large hospital contracts across multiple surgical specialties.
- Medtronic (Neurosurgery): Medtronic's neurosurgery business spans a range of cranial procedures and capital equipment. While Bioplate competes at the implant/fixation layer, Medtronic competes broadly for the neurosurgical dollar across implants, navigation, and capital.
Direct peers
- KLS Martin: KLS Martin is a privately held specialist in cranio-maxillofacial (CMF) surgery implants and instruments, making it a direct comparable to Bioplate's narrow focus on cranial and maxillofacial fixation. Both companies compete in titanium plates/screws, patient-specific implants, and CMF surgical tools.
- Integra LifeSciences: Integra is a leading neurosurgery and CMF-focused medical device company with a portfolio that directly overlaps Bioplate's cranial fixation and dural repair offerings. Its dedicated neurosurgery segment competes head-to-head with Bioplate in cranial plating and reconstruction.
Emerging players
- Osteopore: Osteopore (NUS spin-off, Singapore-based) is the developer and manufacturer of the bioresorbable PCL bone scaffolds Bioplate distributes in the US. While technically a partner/supplier, Osteopore's technology is the closest emerging substitute to Bioplate's core titanium fixation line and represents the most direct technology competitive threat.
- Xtant Medical: Xtant Medical operates in the orthobiologics and fixation space, including bone graft substitutes and craniomaxillofacial products. It competes with Bioplate at the intersection of regenerative implant and fixation technology, particularly around bone void fillers.
Regional players
- Kontour Medical: Kontour is a China-based cranial fixation supplier (now publicly listed in Shanghai per Bioplate's VP Alan Zhu's prior role). It is the primary regional competitor for cranial plating in Asia and parallels Bioplate's narrow cranial-fixation focus.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioplate social profiles
Digital presenceBioplate compliance and trust
Trust signalCompliance1 record
Bioplate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioplate leadership team
Management profileNumber of profiles
Profiles6 records
Bioplate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioplate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioplate
What does Bioplate do?
Bioplate designs, manufactures, and distributes cranial closure and bone fixation hardware for neurosurgery and maxillofacial surgery. Its core offerings include titanium plates and screws, pre-configured sterile kits, the PRO-DEX surgical driver, the AURA wireless intracranial pressure monitor, Osteopore bioresorbable PCL bone scaffolds (Osteoplug, Osteostrip, Osteomesh) distributed in the US, and patient-specific CranioFit PEEK cranial plates manufactured from CT data. Products are sold primarily to hospitals and surgeons through a US distributor network and direct sales.
Is Bioplate a public or private company?
Bioplate is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bioplate founded?
Bioplate was founded in 1995. It employs 11 to 50 people.
Where is Bioplate based?
Bioplate is headquartered in Placentia, United States, in the North America region.
How does Bioplate make money?
Four revenue lines are on record. Medical Device Sales - Cranial Fixation Products are the primary driver. The others are customized PEEK Implants, bioresorbable Bone Scaffold Distribution and contract Manufacturing Services.
Who are Bioplate's main competitors?
Broad incumbents on record are DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Stryker (CMF / Neurotechnology), B. Braun / Aesculap and Medtronic (Neurosurgery). Direct peers are KLS Martin and Integra LifeSciences. Emerging players are Osteopore and Xtant Medical. Kontour Medical is listed as a regional player.
Does Bioplate have an API?
No public API is recorded for Bioplate.
What industry is Bioplate in?
Bioplate's product category is Cranial and Maxillofacial Fixation Implants. Its primary akta.pro industry code is HLAHAEAD, Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts), with a secondary code of HLABAJAH, Maxillofacial Prosthetics & Craniofacial Appliances. Its NAICS code is 339113 and its SIC code is 3842.